Skip to content

Category: tumorSyndicate content

1930s drug slows tumor growth

November 6, 2009

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.

PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer

November 6, 2009

(PHILADELPHIA) A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented

Researcher: 'Optical biopsy' for breast cancer increasingly accurate

November 5, 2009

GAINESVILLE, Fla. -- Most biopsies following mammograms reveal benign abnormalities, not cancer.

New Notre Dame study provides insights into the molecular basis of tumor cell behavior

November 5, 2009

A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor c

Blood vessels might predict prostate cancer behavior

November 3, 2009

COLUMBUS, Ohio -- A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave.

Experimental agent reduces breast cancer metastasis to bone

November 3, 2009

Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.

Study reveals a 'missing link' in immune response to disease

November 2, 2009

BOSTON--The immune system's T cells have the unique responsibilities of being both jury and executioner.

Undetectable PSA after radiation is possible and predicts good patient outcomes

November 2, 2009

CHICAGO (November 2, 2009)??Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer pat

Duke develops nano-scale drug delivery for chemotherapy

November 1, 2009

DURHAM, N.C. -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

Inhibitor of heat shock protein is a potential anticancer drug, Penn study finds

October 29, 2009

PHILADELPHIA - Like yoga for office drones, cells do have coping strategies for stress.

Th17 cells summon an immune system strike against cancer

October 29, 2009

HOUSTON - A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The

UT Southwestern researchers use drug-radiation combo to eradicate lung cancer

October 29, 2009

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients

October 28, 2009

A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.